Clinical Trial Update: Study of Lamotrigine to Treat Ménière's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing lamotrigine for Ménière's disease has completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ménière Disease
• Vertigo

Drugs mentioned

• Lamotrigine (lamotrigine)

Snippet

Sponsor: Dent Neuroscience Research Center | Conditions: Meniere's Disease, Ménière's Vertigo | Phase 2 | Status: COMPLETED | Results posted: 2022-06-22